From gene-editing to Artificial Intelligence (AI), we explore pertinent issues concerning the modern-day fight against malaria.
Controlling malaria is a complicated affair. I speak with John Miller of the global health nonprofit PATH on the role of mass drug administration in reducing malaria prevalence.
An interview with Dr Melanie Renshaw, Chief Policy Officer of the RBM Partnership to End Malaria, to discuss progress against malaria, the funding gap and how access to core malaria interventions will be maintained during the COVID pandemic.
An interview with Dr Ashley Birkett, Director of PATH’s Malaria Vaccine Initiative. We discuss RTS,S and the global health challenges surrounding it, in terms of vaccine adherence and hesitancy.
What if we could genetically modify the mosquito so that it couldn’t transmit malaria? That’s the idea behind gene drives; Justine Rougé explores.